Skip to content

The Effect of Chlorella on Glycemic Control of Diabetes

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01301287
Enrollment
30
Registered
2011-02-23
Start date
2010-01-31
Completion date
Unknown
Last updated
2011-02-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes

Brief summary

Chlorella, a type of unicellular fresh water algae, has been a popular foodstuff in Asia, especially in Taiwan. Recent studies have shown the hypoglycemic effects of Chlorella through increasing glucose uptake in the liver and muscle, lowering serum free fatty acid levels, or activation of PPAR gamma receptor. However, the hypoglycemic effect in diabetic patients have not been studied. In order to clarify the hypoglycemic effects and mechanism of Chlorella in diabetic patients, the investigators conducted a 12-week randomized, double-blind, placebo-control trial on diabetic patients.

Interventions

Sponsors

Tri-Service General Hospital
CollaboratorOTHER
Cardinal Tien Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Caregiver, Investigator)

Eligibility

Sex/Gender
ALL
Age
18 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

* 18-70 years old * type 2 diabetes with less than 2 kinds of oral antidiabetes drugs * Hba1c: 7.0-9.0

Exclusion criteria

* type 1 diabetes * pregnancy * acute infectious disease * autoimmune disease * hemodynamic unstable

Design outcomes

Primary

MeasureTime frame
HbA1c12 weeks

Secondary

MeasureTime frameDescription
Insulin concentration during oral glucose tolerance test12 weeksAll subjects received the first oral glucose tolerance test before intervention(week 0), and the second oral glucose tolerance test on week 12.

Countries

Taiwan

Contacts

Primary ContactFone-Ching Hsiao, MD
foneching.hsiao@gmail.com

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026